Skip Navigation LinksHome > May 1, 2014 - Volume 66 - Issue 1 > Effect of Age on the CD4+ T-Cell Impairment in HIV-Infected...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0000000000000097
Basic and Translational Science

Effect of Age on the CD4+ T-Cell Impairment in HIV-Infected Persons Without and With cART

Allers, Kristina PhD*; Bösel, Diana BTA*; Epple, Hans-Jörg MD*; Karcher, Heiko MD*; Schmidt, Wolfgang MD; Kunkel, Désirée PhD*; Geelhaar-Karsch, Anika PhD*; Schinnerling, Katina PhD*; Moos, Verena PhD*; Schneider, Thomas MD, PhD*

Supplemental Author Material
Collapse Box

Abstract

Background: Knowledge about HIV infection in older persons is becoming increasingly important. CD4+ T cells are essential for protective immunity, but little is known about the effect of age on the CD4+ T-cell impairment in HIV infection.

Methods: Treatment-naive patients aged older than 50 or younger than 40 years were studied for absolute and relative frequencies of CD31+ naive and CD31 naive CD4+ T cells, central memory, effector memory, and terminally differentiated CD4+ T cells, and compared with age-matched controls. In addition, cellular proliferation and cytokine secretion properties were determined. CD4+ T-cell reconstitution was analyzed in older and younger patients with <350 or ≥350 CD4+ T cells per microliter at initiation of combination antiretroviral tharapy (cART).

Results: CD4+ T cells of older but not younger HIV-infected patients showed age-inappropriate low levels of CD31 naive cells, increased levels of effector memory cells, and enhanced interferonγ and interleukin-17 secretion. Impaired CD4+ T-cell composition persisted in patients who initiated cART at <350 CD4+ T cells per microliter. In patients with CD4+ T cells ≥350 per microliter, alterations were less pronounced and were reversible with cART. Compared with age-matched controls, total CD4+ T-cell counts did not differ between treated younger and older HIV-infected patients.

Conclusions: These data demonstrate that aging enhances the CD4+ T-cell impairment in HIV-infected persons mainly by a loss of CD31 naive cells, accumulation of effector memory cells, and increased pro-inflammatory effector functions. Age-related changes in CD4+ T-cell composition can be prevented by an early initiation of cART.

© 2014 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.